Ligand Pharmaceuticals Inc (NASDAQ:LGND)
| 106.10 Delayed Data As of Aug 17 |  -1.52 / -1.41%Today’s Change | 72.57 Today|||52-Week Range 169.98 | -31.31% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Foehr Matthew William President & Chief Operating Officer |  Sale | 11/11/2021 | 11,160 | $163.02 | $1.8M | -34.60% |
Lamattina John L Director | Sale | 11/16/2021 | 4,835 | $161.86 | $782.6K | -34.33% |
Higgins John L Chief Executive Officer | Sale | 1/26/2022 | 6,183 | $113.68 | $702.9K | -6.72% |
Higgins John L Chief Executive Officer | Sale | 11/12/2021 | 3,000 | $160.50 | $481.5K | -34.30% |
Foehr Matthew William President & Chief Operating Officer | Sale | 1/26/2022 | 3,188 | $113.68 | $362.4K | -6.72% |
Higgins John L Chief Executive Officer | Sale | 1/26/2022 | 3,060 | $113.68 | $347.9K | -6.72% |
Korenberg Matthew Edward | Sale | 1/26/2022 | 2,309 | $113.68 | $262.5K | -6.72% |
Higgins John L Chief Executive Officer | Sale | 2/15/2022 | 2,061 | $123.68 | $254.9K | -14.26% |
Foehr Matthew William President & Chief Operating Officer |  Buy | 11/11/2021 | 11,160 | $21.92 | $244.6K | -34.60% |
Higgins John L Chief Executive Officer | Sale | 2/15/2022 | 1,946 | $123.68 | $240.7K | -14.26% |
Page of 6